CPHI·16941T401·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic
CPHI (CHINA PHARMA HLDGS INC) is held by 5 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($7,884), RENAISSANCE TECHNOLOGIES LLC ($6,965), CITIGROUP INC ($608). Net institutional sentiment: Bullish.
See how CPHI's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer